Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial
2016 ◽
Vol 128
(3)
◽
pp. 405-415
◽
2016 ◽
Vol 8
(343)
◽
pp. 343re2-343re2
◽
2005 ◽
Vol 25
(1_suppl)
◽
pp. S274-S274